This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Agenus Inc
AGEN : NASDAQ : Health Care
$2.88 -0.04 | -1.37%
Today's Range: 2.86 - 2.94
Avg. Daily Volume: 883,000
09/22/14 - 4:00 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
AGEN AGENUS INC 2.98 186.78 n/m 4.92 27.01
PLX PROTALIX BIOTHERAPEUTICS INC 2.54 237.91 n/m 14.55 16.68
BSTC BIOSPECIFICS TECHNOLOGIES CP 33.61 217.69 55.10 12.63 -4.37
IDRA IDERA PHARMACEUTICALS INC 2.54 212.77 n/m 0.05 4.00
PSTI PLURISTEM THERAPEUTICS INC 2.93 202.99 n/m 0.38 -44.19
NAVB NAVIDEA BIOPHARMACEUTICALS 1.33 200.35 n/m 2.76 1267.32
CBMG CELLULAR BIOMEDICINE GROUP 20.40 185.17 n/m 4.14 413700.00
NBS NEOSTEM INC 5.20 183.63 n/m 16.33 16.07
STML STEMLINE THERAPEUTICS INC 13.53 179.38 n/m 0.21 n/a
KMDA KAMADA LTD 4.60 165.42 n/m 70.90 146.92
ICEL CELLULAR DYNAMICS INTL INC 9.78 154.16 n/m 13.26 371.44
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

AGEN Ind Avg S&P 500
n/m 82.53 19.94

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs